A Look Into Pfizer's Debt

Over the past three months, shares of Pfizer Inc. PFE fell by 3.57%. Before having a look at the importance of debt, let's look at how much debt Pfizer has.

Pfizer's Debt

Based on Pfizer’s balance sheet as of May 7, 2020, long-term debt is at $36.28 billion and current debt is at $16.01 billion, amounting to $52.29 billion in total debt. Adjusted for $2.15 billion in cash-equivalents, the company's net debt is at $50.14 billion.

Shareholders look at the debt-ratio to understand how much financial leverage a company has. Pfizer has $166.34 billion in total assets, therefore making the debt-ratio 0.31. As a rule of thumb, a debt-ratio more than 1 indicates that a considerable portion of debt is funded by assets. A higher debt-ratio can also imply that the company might be putting itself at risk for default, if interest rates were to increase. However, debt-ratios vary widely across different industries. For example, a debt ratio of 40% might be higher for one industry, whereas normal for another.

Importance of Debt

Besides equity, debt is an important factor in the capital structure of a company, and contributes to its growth. Due to its lower financing cost compared to equity, it becomes an attractive option for executives trying to raise capital.

However, interest-payment obligations can have an adverse impact on the cash-flow of the company. Equity owners can keep excess profit, generated from the debt capital, when companies use the debt capital for its business operations.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Intraday UpdateMarketsDebt overview
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!